A Peripherally Inserted Central Catheters Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade

Peripherally Inserted Central Catheters Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Peripherally inserted central catheters (PICCs) stand as a vital subtype of catheters, specifically designed for intravenous (IV) administration, particularly for continuous therapy lasting from over a week to less than five weeks. With indications spanning chemotherapy drugs, parenteral nutrition, blood sample withdrawal, and more, the choice of PICCs is contingent upon the therapy duration and disease type. The market segregates PICCs into two types: power-injected PICCs and conventional PICCs.

Market Value and Forecast

According to recent analysis, the global PICCs market is poised to exhibit a Compound Annual Growth Rate (CAGR) of 5.8% from 2024 to 2031, in terms of value. By the end of 2024, the market value is projected to soar to US$ 1058.6 million, underscoring the escalating demand for these medical devices.

Market Dynamics

The growth trajectory of the global PICCs market is propelled by various factors, including the burgeoning healthcare expenditure worldwide, robust reimbursement policies, healthcare professionals' growing preference for PICCs, and the rising incidence of diseases necessitating PICC application. Nevertheless, challenges such as the escalating utilization of midline catheters, shortage of specialized catheterization professionals, and the elevated risk of bloodstream infections and deep vein thrombosis pose hurdles to market growth over the forecast period.

Technological Advancements Pave the Way for Future Growth

The future landscape of the global PICCs market is shaped by continuous technological advancements and innovative demands. Recent breakthroughs, such as the introduction of anti-microbial PICCs and anti-thrombogenic PICCs, have revolutionized the industry, offering enhanced safety and efficacy in catheterization procedures. These developments herald a promising future for the PICCs market, underscoring its significance in modern healthcare practices.

The global peripherally inserted central catheters (PICCs) market is strategically segmented across five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North American PICCs market held a commanding revenue share, significantly dominating the global market. Over the forecast period, this region is anticipated to sustain steady growth.

Meanwhile, the Asia Pacific (APAC) and European markets are poised to emerge as the frontrunners in terms of growth rate, showcasing promising expansion. With evolving healthcare infrastructures and increasing adoption of advanced medical technologies, these regions are anticipated to witness accelerated demand for PICCs, reflecting the growing significance of these devices in modern healthcare practices.



Key Companies
• Global Players
• AngioDynamic, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• C. R. Bard, Inc.
• Teleflex Incorporated
• Argon Medical Devices, Inc.
• Boston Scientific Corporation
• COOK MEDICAL INC.
• ICU Medical Inc.
• Medical Components, Inc.
• Medtronic, Inc
• Navilyst Medical, Inc.
• Vygon (UK) Ltd
• Others.

Market Segmentation:

The global peripherally inserted central catheters market is segmented as under:

By Product
• Power Injected Peripherally Inserted Central Catheters
• Conventional Peripherally Inserted Central Catheters

By Design
• Single Lumen
• Double Lumen
• Multiple Lumen

By End User
• Hospitals
• Ambulatory Surgical Centers
• Catheterization Laboratories

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.